These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 23587083)

  • 1. Commentary on Boileau et al. (2013): Distinguishing D2/D3 dopaminergic contributions to addictions.
    Potenza MN; Brody AL
    Addiction; 2013 May; 108(5):964-5. PubMed ID: 23587083
    [No Abstract]   [Full Text] [Related]  

  • 2. The D2/3 dopamine receptor in pathological gambling: a positron emission tomography study with [11C]-(+)-propyl-hexahydro-naphtho-oxazin and [11C]raclopride.
    Boileau I; Payer D; Chugani B; Lobo D; Behzadi A; Rusjan PM; Houle S; Wilson AA; Warsh J; Kish SJ; Zack M
    Addiction; 2013 May; 108(5):953-63. PubMed ID: 23167711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopamine and Opioid Neurotransmission in Behavioral Addictions: A Comparative PET Study in Pathological Gambling and Binge Eating.
    Majuri J; Joutsa J; Johansson J; Voon V; Alakurtti K; Parkkola R; Lahti T; Alho H; Hirvonen J; Arponen E; Forsback S; Kaasinen V
    Neuropsychopharmacology; 2017 Apr; 42(5):1169-1177. PubMed ID: 27882998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopamine release in ventral striatum during Iowa Gambling Task performance is associated with increased excitement levels in pathological gambling.
    Linnet J; Møller A; Peterson E; Gjedde A; Doudet D
    Addiction; 2011 Feb; 106(2):383-90. PubMed ID: 20883460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. On cue: striatal ups and downs in addictions.
    Leyton M; Vezina P
    Biol Psychiatry; 2012 Nov; 72(10):e21-2. PubMed ID: 22789688
    [No Abstract]   [Full Text] [Related]  

  • 6. The anticipatory dopamine response in addiction: A common neurobiological underpinning of gambling disorder and substance use disorder?
    Linnet J
    Prog Neuropsychopharmacol Biol Psychiatry; 2020 Mar; 98():109802. PubMed ID: 31678482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for GABA-A receptor dysregulation in gambling disorder: correlation with impulsivity.
    Mick I; Ramos AC; Myers J; Stokes PR; Chandrasekera S; Erritzoe D; Mendez MA; Gunn RN; Rabiner EA; Searle GE; Galduróz JCF; Waldman AD; Bowden-Jones H; Clark L; Nutt DJ; Lingford-Hughes AR
    Addict Biol; 2017 Nov; 22(6):1601-1609. PubMed ID: 27739164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of alcohol craving with striatal dopamine synthesis capacity and D2/3 receptor availability: a combined [18F]DOPA and [18F]DMFP PET study in detoxified alcoholic patients.
    Heinz A; Siessmeier T; Wrase J; Buchholz HG; Gründer G; Kumakura Y; Cumming P; Schreckenberger M; Smolka MN; Rösch F; Mann K; Bartenstein P
    Am J Psychiatry; 2005 Aug; 162(8):1515-20. PubMed ID: 16055774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The distribution of D2/D3 receptor binding in the adolescent rhesus monkey using small animal PET imaging.
    Christian BT; Vandehey NT; Fox AS; Murali D; Oakes TR; Converse AK; Nickles RJ; Shelton SE; Davidson RJ; Kalin NH
    Neuroimage; 2009 Feb; 44(4):1334-44. PubMed ID: 19015034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binding of the D3-preferring antipsychotic candidate F17464 to dopamine D3 and D2 receptors: a PET study in healthy subjects with [
    Slifstein M; Abi-Dargham A; Girgis RR; Suckow RF; Cooper TB; Divgi CR; Sokoloff P; Leriche L; Carberry P; Oya S; Joseph SK; Guiraud M; Montagne A; Brunner V; Gaudoux F; Tonner F
    Psychopharmacology (Berl); 2020 Feb; 237(2):519-527. PubMed ID: 31773210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selectivity of probes for PET imaging of dopamine D3 receptors.
    Doot RK; Dubroff JG; Labban KJ; Mach RH
    Neurosci Lett; 2019 Jan; 691():18-25. PubMed ID: 29518538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopaminergic signaling of uncertainty and the aetiology of gambling addiction.
    Zack M; St George R; Clark L
    Prog Neuropsychopharmacol Biol Psychiatry; 2020 Apr; 99():109853. PubMed ID: 31870708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Challenges in the development of dopamine D2- and D3-selective radiotracers for PET imaging studies.
    Mach RH; Luedtke RR
    J Labelled Comp Radiopharm; 2018 Mar; 61(3):291-298. PubMed ID: 28857231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preferential binding to dopamine D3 over D2 receptors by cariprazine in patients with schizophrenia using PET with the D3/D2 receptor ligand [(11)C]-(+)-PHNO.
    Girgis RR; Slifstein M; D'Souza D; Lee Y; Periclou A; Ghahramani P; Laszlovszky I; Durgam S; Adham N; Nabulsi N; Huang Y; Carson RE; Kiss B; Kapás M; Abi-Dargham A; Rakhit A
    Psychopharmacology (Berl); 2016 Oct; 233(19-20):3503-12. PubMed ID: 27525990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced striatal dopamine D2 receptors in people with Internet addiction.
    Kim SH; Baik SH; Park CS; Kim SJ; Choi SW; Kim SE
    Neuroreport; 2011 Jun; 22(8):407-11. PubMed ID: 21499141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Separating dopamine D
    Smart K; Gallezot JD; Nabulsi N; Labaree D; Zheng MQ; Huang Y; Carson RE; Hillmer AT; Worhunsky PD
    Neuroimage; 2020 Jul; 214():116762. PubMed ID: 32201327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heightened D3 dopamine receptor levels in cocaine dependence and contributions to the addiction behavioral phenotype: a positron emission tomography study with [11C]-+-PHNO.
    Payer DE; Behzadi A; Kish SJ; Houle S; Wilson AA; Rusjan PM; Tong J; Selby P; George TP; McCluskey T; Boileau I
    Neuropsychopharmacology; 2014 Jan; 39(2):311-8. PubMed ID: 23921256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding characteristics and sensitivity to endogenous dopamine of [11C]-(+)-PHNO, a new agonist radiotracer for imaging the high-affinity state of D2 receptors in vivo using positron emission tomography.
    Ginovart N; Galineau L; Willeit M; Mizrahi R; Bloomfield PM; Seeman P; Houle S; Kapur S; Wilson AA
    J Neurochem; 2006 May; 97(4):1089-103. PubMed ID: 16606355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular Imaging of Addictive Behavior in Idiopathic Parkinson's Disease.
    Ghadery C; Valli M; Mihaescu A; Strafella R; Navalpotro I; Kim J; Strafella AP
    Int Rev Neurobiol; 2018; 141():365-404. PubMed ID: 30314604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopaminergic function and intertemporal choice.
    Joutsa J; Voon V; Johansson J; Niemelä S; Bergman J; Kaasinen V
    Transl Psychiatry; 2015 Jan; 5(1):e491. PubMed ID: 25562841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.